XML 53 R44.htm IDEA: XBRL DOCUMENT v3.23.2
Stock-Based Compensation Plans - Stock Options and Performance Awards (Details) - $ / shares
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Options    
Exercised (in shares) (5,773)  
Employee and Directors Stock Options | Stock Option and Incentive Plan 2009    
Options    
Options Outstanding at beginning of period (in shares) 293,813  
Granted (in shares) 15,744  
Exercised (in shares) (5,773)  
Forfeited (in shares) 0  
Options Outstanding at end of period (in shares) 303,784  
Options Exerciseable (in shares) 279,894  
Weighted average exercise price per option    
Weighted average exercise price of options outstanding at beginning of period (in dollars per share) $ 181.85  
Weighted average exercise price of options granted (in dollars per share) 177.83  
Weighted average exercise price of options exercised (in dollars per share) 163.56  
Weighted average exercise price of options forfeited (in dollars per share) 0  
Weighted average exercise price of options outstanding at end of period (in dollars per share) 181.99  
Weighted average exercise price of options exercisable (in dollars per share) $ 180.97  
Performance Shares    
Performance awards    
Equity instruments outstanding at the beginning of the period (in shares) 279,067  
Equity instruments granted (in shares) 89,977  
Change in awards based on performance (in shares) (31,345)  
Converted to shares of common stock (in shares) (60,016) (54,053)
Forfeited (in shares) (2,719)  
Equity instruments outstanding at the end of the period (in shares) 274,964  
Weighted average grant date fair value per award    
Equity instruments outstanding at the beginning of the period (in dollars per share) $ 225.46  
Grant date fair value per share (in dollars per share) 193.88  
Change in awards based on performance (in dollars per share) 241.49  
Converted to shares of common stock (in dollars per share) 238.71  
Forfeited (in dollars per share) 212.05  
Equity instruments outstanding at the end of the period (in dollars per share) $ 210.54  
Grants in period based on total shareholder metrics (in shares) 49,480  
Grants in period based on financial metrics (in shares) 40,497